Abbott's Genetic Test For Acute Myeloid Leukemia Prognosis Cleared By FDA

Links shared publicly online about this topic.

  • 0
    total visits

Abbott's Genetic Test For Acute Myeloid Leukemia Prognosis Cleared By FDA

medicalnewstoday.com —

Abbott (NYSE: ABT) announced it has received 510(k) clearance from the U.S. Food and Drug Administration for a new in vitro diagnostic test to aid in determining the prognosis of patients with acu

View full resource at medicalnewstoday.com

Tags: Genetic, Cancer, Leukemia, Lymphoma, Diet and Nutrition, Lab Test, FDA, Abbott Laboratories

  • Share

Most Recently Shared on October 28, 2011 at 12:05 pm By:

mnt_medicaldev MNT Medical Devices

Abbott's Genetic Test For Acute Myeloid Leukemia Prognosis Cleared By FDA http://t.co/UHnCR36Z #medicaldevices

6 months ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Leukemia MNT Leukemia

MNT Genetics News MNT Genetics News

Advertisement